C
Chemomab Therapeutics Ltd D
D
CMMB
1.24000
USD
0.04
(3.33%)
مغلق
حجم التداول
659
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
23,763,061
العنوان: Chemomab Therapeutics Ltd
القطاع: Healthcare
الصناعة: Biotechnology
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.